XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Cash flows from operating activities:      
Net income (loss) $ 3,974 $ 16,635  
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for losses on accounts receivable 0 (3)  
Reversal of gain on sales to equity method investee (3) 0  
Depreciation and amortization 21,108 14,575  
Deferred income tax expense (5,259) (1,185)  
Income tax expense arising from restricted share vesting and stock options exercised (333) (587)  
Stock-based compensation expense 947 1,558  
Income from equity method investment (3,676) (5,943)  
Gain on disposition of property and equipment 702 (9,791)  
Changes in operating assets and liabilities:      
Receivables and advances 3,812 2,863  
Prepaid expenses and other assets 3,946 2,555  
Inventory and supplies (279) 208  
Insurance and claims accrual 5,310 (324)  
Accounts payable and accrued expenses (8,548) (13,313)  
Net cash flows provided by operating activities 21,701 7,248  
Cash flows from investing activities:      
Acquisition, net of cash acquired (4,556) 0  
Other investments (156) (1,108)  
Purchase of property and equipment (48,362) (16,221)  
Proceeds from disposition of property and equipment 9,593 24,407  
Net cash flows (used) provided by investing activities (43,481) 7,078  
Cash flows from financing activities:      
Change in checks outstanding in excess of bank balances 918 0  
Cash dividend (1,443) (1,466)  
Proceeds from issuance of notes payable 52,179 12,795  
Repayments of notes payable (10,540) (4,902)  
Repayments of finance lease obligations (162) (3,357)  
Proceeds under revolving credit facility 14,550 10,665  
Repayments under revolving credit facility and draw note (26,130) (10,665)  
Payment of contingent consideration liability (7,023) (9,187)  
Proceeds from exercise of stock options 428 0  
Payment of minimum tax withholdings on stock compensation (339) (1,485)  
Common stock repurchased 0 (20,805)  
Net cash flows provided (used) by financing activities 22,438 (28,407)  
Net change in cash and cash equivalents 658 (14,081)  
Cash and cash equivalents at beginning of period 2,294 68,665 $ 68,665
Cash and cash equivalents at end of period $ 2,952 $ 54,584 $ 2,294